
Is A (Agilent Technologies, Inc.) Halal or Haram?
Agilent Technologies easily clears all AAOIFI shariah screening criteria, making it a strong candidate for Muslim investors. The company's debt-to-market cap ratio sits at a conservative 10.4%, well below the 33% threshold, while its interest-bearing income is negligible at just 0.89% of total revenue. Furthermore, its cash and securities represent only 5.6% of its market cap, ensuring full compliance across all financial screens.
Price Chart (5D)
A — Last 7 Days
| Date | Open | High | Low | Close | Volume | Change |
|---|---|---|---|---|---|---|
| 2026-05-01 | 116.13 | 116.28 | 113.84 | 114.52 | 1.3M | -1.39% |
| 2026-04-30 | 111.81 | 115.98 | 111.33 | 115.55 | 2.2M | +3.34% |
| 2026-04-29 | 114.19 | 115.53 | 110.31 | 111.30 | 2.1M | -2.53% |
| 2026-04-28 | 116.23 | 116.64 | 114.10 | 114.87 | 2.1M | -1.17% |
| 2026-04-27 | 115.18 | 117.33 | 115.18 | 115.62 | 1.5M | +0.38% |
| 2026-04-24 | 114.57 | 116.51 | 114.21 | 115.55 | 1.5M | +0.86% |
| 2026-04-23 | 116.50 | 116.79 | 111.98 | 114.42 | 2.6M | -1.79% |
Discussion
Sign in to join the discussion
Loading comments...
Shariah Screening Details for A
Business Activity
Permissible
Agilent's core business of manufacturing life sciences equipment, such as chromatography and mass spectrometry systems for medical diagnostics and research, is fully permissible under Islamic principles.
Debt / Market Cap
10.44%
Interest Income
0.89%
Cash & Securities
5.57%
About Agilent Technologies, Inc. (A)
Agilent Technologies, Inc. is a global leader in the life sciences and diagnostics sectors, providing advanced laboratory equipment and application-focused solutions. The company specializes in manufacturing highly technical instruments like liquid and gas chromatography systems, as well as mass spectrometry devices used extensively in research and applied chemical markets.
For Muslim investors, Agilent Technologies represents a fully Halal investment opportunity within the healthcare sector. The stock successfully passes all four AAOIFI shariah screens, meaning both its core medical research business activities and its underlying financial structures align perfectly with Islamic finance principles.
From a financial perspective, Agilent demonstrates a highly disciplined balance sheet that is well-suited for halal portfolios. The company's debt-to-market cap ratio is notably low at 10.4%, and its interest-bearing income accounts for a mere 0.89% of total revenue, strictly limiting any exposure to riba (usury).
Because Agilent operates in the broadly permissible sector of medical diagnostics and scientific research, there is no significant scholarly debate regarding its core operations. Moving forward, halal investors should simply monitor its quarterly debt and cash levels to ensure its financial ratios remain safely below the 33% AAOIFI thresholds.
CEO
Padraig McDonnell
Employees
17,900
IPO Date
1999-11-18
Headquarters
Santa Clara, CA, US
Website
www.agilent.comA Key Financial Statistics
Revenue
$6.95B
Net Income
$1.30B
EPS (Diluted)
$4.57
Stock Price
113.73
Beta
1.30
52-Week Range
104.1-160.27
Total Debt
$3.35B
Total Equity
$6.74B
Current Ratio
1.96
A Financial Health & Profitability
Profit Margins
Revenue Growth (YoY)
+6.7%
Prior year: $6.51B
Net Debt
$1.56B
Cash: $1.79B — Debt: $3.35B
R&D Spending
$455.0M
% of Revenue
6.5%
Frequently Asked Questions About A
Is A (Agilent Technologies, Inc.) stock halal to invest in?▾
What does Agilent Technologies, Inc. do?▾
What screening criteria were used for A?▾
Does A require income purification?▾
When was A last screened?▾
Disclaimer
This shariah compliance assessment for A (Agilent Technologies, Inc.) is provided for informational purposes only and does not constitute financial, investment, or religious advice. Screening criteria are based on widely accepted AAOIFI standards, but individual scholars may differ in their opinions. Always consult with a qualified Islamic scholar and licensed financial advisor before making investment decisions. Past screening status does not guarantee future compliance. Last screened: 2026-04-29.